Infectious diseases

Prof Paul Griffin
Podcasts iconPodcasts

Ba2, Deltacron, Omicron and other variants- the winter booster - for which patients? An update on the other vaccines and the COVID antivirals.

Dr Linda Calabresi
Clinical Articles iconClinical Articles

Despite the increasing numbers of infections, Covid vaccines are still effective, particularly if people are fully vaccinated, says Dr Paul Griffin, Director of Infectious Diseases at the Mater in Queensland.

Prof Andrew Sindone
Videos iconVideos

In this Product Explainer, Prof Andrew Sindone, Cardiologist and Director of the Heart Failure Unit at the Concord Hospital explains the cardiovascular advantages of a high-dose quadrivalent influenza vaccine for active immunisation for the prevention of influenza disease indicated for use in persons 60 years of age and older (5 mins).

Dr Linda Calabresi
Clinical Articles iconClinical Articles

With long COVID becoming recognised as a significant consequence of COVID infection, it is evident we will need to stay ahead of prevention and treatment of the new variants of this virus

Prof Peter Richmond
Videos iconVideos

In this Product Explainer, Paediatrician and Paediatric Immunologist A/Prof Peter Richmond explains which patients are most at risk for meningococcal B, the risk reduction benefits of meningococcal B vaccination and why it is important to have conversations with parents in which the risk/benefits of vaccination are clearly explained (5 mins).

Prof Robert Booy
Podcasts iconPodcasts

Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?

Dr Lisa Beecham
Podcasts iconPodcasts

Key features of pertussis as it appears in adults, when to suspect it, and how to diagnose and treat it- the opportunities that exist to reduce the morbidity and mortality from whooping cough by targeting older adults.

Prof Tony Cunningham AO
Videos iconVideos

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

A/Prof Nigel Crawford
Podcasts iconPodcasts

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Prof Tony Cunningham AO
Podcasts iconPodcasts

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Prof Christine Jenkins
Podcasts iconPodcasts

COVID is not the only preventable infectious disease - influenza, pertussis, and pneumonia are also very important

A/Prof John Litt AM
Videos iconVideos

In this Product Explainer, A/Prof John Litt AM, Public Health Physician explains the differences between the “traditional” egg-based influenza vaccines and the potential advantages of the first cell culture based influenza vaccine available in Australia (5 mins).